 NEW YORK, March 8, 2021 PRNewswire -- Hoth Therapeutics, Inc. NASDAQ: HOTH, a patient focused clinical stage biopharmaceutical company, today announced that it has entered into a definitive agreement with certain institutional and accredited investors for the issuance and sale of an... 